SCHEMBL19080091

SCHEMBL19080091

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5ccc6cc7c(cc6c5)oc5c6ccccc6c6ccccc6c75)c5ccccc45)c4ccccc34)ccc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.35
GSTP1 P09211 1/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
MIF P14174 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
PRKDC P78527 1/20 0.32
ARSA P15289 1/20 0.32
CDC25A P30304 1/20 0.32
CDC25C P30307 1/20 0.32
ALOX5 P09917 1/20 0.32
MTOR P42345 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
TSHR P16473 1/20 0.30
CYP2C19 P33261 1/20 0.30
SOS1 Q07889 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080085 0.95 CYP1A1 (0.35) GPR84GSTP1CYP1A1CYP1B1MIF
SCHEMBL19080028 0.93 ESR1 (0.36) GPR84CYP1A1ARSACDC25ACDC25C
SCHEMBL19080057 0.92 ALOX5 (0.36) GPR84CYP1A1CYP1B1PRKDCARSA
SCHEMBL17931968 0.92 GPR84 (0.36) GPR84GSTP1CYP1A1CYP1B1MIF
SCHEMBL19080109 0.91 CYP1A1 (0.37) GPR84GSTP1CYP1A1CYP1B1MIF
SCHEMBL19080074 0.89 ALOX5 (0.34) CYP1A1CYP1B1PRKDCARSACDC25A
SCHEMBL19079991 0.89 ESR1 (0.36) GPR84CYP1A1CYP1B1ALOX5CYP1A2
SCHEMBL19080025 0.87 ESR1 (0.35) GPR84ARSACDC25ACDC25CALOX5
SCHEMBL19080083 0.87 CYP1A1 (0.45) GPR84GSTP1CYP1A1CYP1B1MIF
SCHEMBL19080104 0.86 CYP1A1 (0.39) GPR84GSTP1CYP1A1CYP1B1MIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 GPR84 2425/4885GSTP1 1966/4885CYP1A1 147/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 GPR84 2425/4885GSTP1 1966/4885CYP1A1 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.